Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYCR1 | P32322 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 7/20 | 0.31 |
| ▸ | MAOA | P21397 | 5/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26550971 | 0.84 | ACHE (0.34) | PYCR1 | |
| SCHEMBL24029756 | 0.75 | — | — | |
| SCHEMBL24029923 | 0.74 | ALDH1A1 (0.34) | — | |
| Hydrochloric Acid SCHEMBL15020816 | 0.74 | SLC6A2 (0.33) | PYCR1SLC6A2SLC6A4MAOBMAOA | |
| SCHEMBL20024599 | 0.74 | — | — | |
| SCHEMBL26550964 | 0.73 | POLB (0.31) | — | |
| Hydrochloric Acid SCHEMBL8943334 | 0.72 | LMNA (0.41) | PYCR1MAOBMAOA | |
| SCHEMBL24029769 | 0.70 | CHRM2 (0.40) | MAOBMAOA | |
| SCHEMBL11726630 | 0.70 | — | — | |
| SCHEMBL11255811 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114423775-B | Aryl glucoside derivative, and preparation method and application thereof | 上海喆邺生物科技有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20230365610-A1 | Aryl Glucoside Derivative | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230365610-A1 | Aryl Glucoside Derivative | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230331760-A1 | ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| US-20230331761-A1 | Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| US-20230331761-A1 | Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| CN-115003661-B | Aryl glucoside derivative and application thereof in medicines | 上海喆邺生物科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-114599643-B | Aryl glucoside derivative | 上海喆邺生物科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-115003661-A | Aryl glucoside derivatives and their use in medicine | 上海喆邺生物科技有限公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-114599643-A | Aryl glucoside derivative | 上海喆邺生物科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114423775-A | Aryl glucoside derivatives, and preparation method and application thereof | 上海喆邺生物科技有限公司 | 2022-04-29 | — | — | CN | disclosed |
| WO-2021227439-A1 | ARYL GLUCOSIDE DERIVATIVE | 上海喆邺生物科技有限公司 | 2021-11-18 | — | — | WO | disclosed |
| WO-2021227441-A1 | ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG | 上海喆邺生物科技有限公司 | 2021-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331761-A1 | Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof | SLC5A1, SLC5A2, SLC10A1 | PYCR1 1632/4885SLC6A2 87/4885SLC6A4 64/4885 |
| US-20230331760-A1 | ARYL GLUCOSIDE DERIVATIVE AND USE THEREOF IN DRUG | SLC5A1, SLC5A2, SLC10A1 | PYCR1 1592/4885SLC6A2 93/4885SLC6A4 62/4885 |
| US-20230365610-A1 | Aryl Glucoside Derivative | SLC5A1, SLC5A2, SLC10A1 | PYCR1 1607/4885SLC6A2 50/4885SLC6A4 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.